Current Treatment Options in Cardiovascular Medicine心血管医学当前治疗选择
Current Treatment Options in Cardiovascular Medicine(英文缩写 CURR TREAT OPT CARD),ISSN 1092-8464,eISSN 1534-3189,中文译名:心血管医学当前治疗选择 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-27 至 2026-09-27，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2023 | 0.800 | Q4 |
| 2024 | 0.600 | Q4 |
| 2025 | 1.100 | Q4 |
Current Treatment Options in Cardiovascular Medicine 最新收录文献
-
1. The Role of Home-Based Exercise in the Management of Peripheral Artery Disease.
1. 家庭运动在外周动脉疾病管理中的作用PMID:日期:2026-12-01Supervised-exercise therapy (SET) is a cornerstone intervention for management of peripheral artery disease (PAD) and is associated with improvement in ambulatory functional status. Despite strong evidence supporting the benefits of SET, accessibility and adherence remains a challenge, underling its full clinical potential. Home-based exercise therapy (HBET) has emerged as more accessible alternative to SET. This paper reviews the benefits of exercise in PAD, explores the role of home-based exercise therapy in the management of PAD, and describes the essential components of HBET in contemporary clinical practice. HBET programs have demonstrated similar improvements in ambulatory function, including walking distance and pain-free walking distance, as established SET regimens. Recent clinical trials and meta-analysis have established HBET as a reasonable alternative to SET, as reflected in the latest multi-societal clinical guidelines. Functional and quality of life improvements with HBET parallel those with SET and outperform routine exercise education. Successful HBET should include both monitoring and behavioral intervention components to improve adherence and long-term symptomatic improvements. Providers should tailor HBET to the individual patient's needs and limitations. Ongoing research aims to understand the optimal platform to deliver HBET programs to a wide range of patients with symptomatic PAD.
-
2. Exercise and Sport Participation in Pediatric Hypertrophic Cardiomyopathy: A Changing Paradigm.
PMID:日期:2026-01-01This review aims to detail recent research and guidelines that have changed the approach to exercise and sport participation in the pediatric hypertrophic cardiomyopathy (HCM) population. Recent studies, including the landmark LIVE-HCM cohort, demonstrated that vigorous exercise was not associated with death, implantable cardiac defibrillator (ICD) shock, resuscitated cardiac arrest, or arrhythmic syncope in patients with HCM. Furthermore, there is increasing evidence that restriction from physical activity (PA) has negative consequences for the cardiovascular health and emotional well-being of children with HCM. This has influenced guidelines that promote individualized risk assessment and shared decision-making (SDM), rather than uniform restriction, in children with HCM who wish to participate in both recreational and competitive athletics. The relationship between PA and cardiac events in children and adults with HCM is more nuanced than once believed, and the negative consequences of uniform PA restrictions have become increasingly clear. Guided by recent prospective cohort studies, the approach to adolescents and young adults with HCM is changing, now emphasizing the role of individualized risk assessment and SDM.
-
3. Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.
PMID:日期:2025-12-01The purpose of this work is to review the role of drug-coated balloons (DCBs) in contemporary coronary artery disease (CAD) management by focusing on its clinical indications and technical considerations, supported by updated insights from the International DCB Consensus Group. While percutaneous coronary intervention (PCI) and drug-eluting stents were initially the standard treatment for CAD, limitations such in-stent stenosis, neoatherosclerosis, and increased bleeding led to the development of the novel DCBs. These DCBs have become well established in treating various clinical cases such as in-stent restenosis, de-novo small-vessel disease, bifurcation lesions, large-vessel disease, high bleeding risk, acute coronary syndromes, and diabetes mellitus. For optimal DCB outcomes, functional assessments, careful lesion preparation, and patient selection are crucial for effective drug delivery and reduced complications. Ongoing innovations in drug formulations, balloon design, and delivery mechanisms, along with further trials, will expand DCBs' impact in CAD treatment.
-
4. The Digital Revolution in Medicine: Applications in Cardio-Oncology.
PMID:日期:2025-12-01A critical evaluation of contemporary literature regarding the role of big data, artificial intelligence, and digital technologies in precision cardio-oncology care and survivorship, emphasizing innovative and groundbreaking endeavors. Artificial intelligence (AI) algorithm models can automate the risk assessment process and augment current subjective clinical decision tools. AI, particularly machine learning (ML), can identify medically significant patterns in large data sets. Machine learning in cardio-oncology care has great potential in screening, diagnosis, monitoring, and managing cancer therapy-related cardiovascular complications. To this end, large-scale imaging data and clinical information are being leveraged in training efficient AI algorithms that may lead to effective clinical tools for caring for this vulnerable population. Telemedicine may benefit cardio-oncology patients by enhancing healthcare delivery through lowering costs, improving quality, and personalizing care. Similarly, the utilization of wearable biosensors and mobile health technology for remote monitoring holds the potential to improve cardio-oncology outcomes through early intervention and deeper clinical insight. Investigations are ongoing regarding the application of digital health tools such as telemedicine and remote monitoring devices in enhancing the functional status and recovery of cancer patients, particularly those with limited access to centralized services, by increasing physical activity levels and providing access to rehabilitation services. In recent years, advances in cancer survival have increased the prevalence of patients experiencing cancer therapy-related cardiovascular complications. Traditional cardio-oncology risk categorization largely relies on basic clinical features and physician assessment, necessitating advancements in machine learning to create objective prediction models using diverse data sources. Healthcare disparities may be perpetuated through AI algorithms in digital health technologies. In turn, this may have a detrimental effect on minority populations by limiting resource allocation. Several AI-powered innovative health tools could be leveraged to bridge the digital divide and improve access to equitable care.
-
5. An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.
PMID:日期:2025-01-01This review provides a practical, evidence-based summary of the physiology, major trial data and clinical role of renal denervation in the treatment of hypertension. The cornerstone of hypertension therapy remains anti-hypertensive medications although this strategy has significant limitations with poor rates of blood pressure control for most patients. Renal denervation was designed to bypass concerns about medication adherence and provide an "always-on" treatment. Recent trial data and meta-analyses are presented demonstrating a modest, although heterogeneous, response to renal denervation which led to the treatment's recent FDA approval. Improvements in catheter design and renal artery treatment strategy may underlie the improved clinical response to denervation in more recent trials. Hypertension centers involving multi-disciplinary care teams are equipped to provide patients with advanced diagnostic testing for secondary hypertension, comprehensive non-invasive management strategies and invasive renal denervation to address hypertension. Early referral for patients with uncontrolled hypertension can provide patients with nuanced conservative and interventional options which have the potential to improve hypertension related morbidity and mortality. Future studies are needed to identify which patients are most likely to respond to renal denervation.
-
6. Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.
PMID:日期:2025-01-01The need for treatments and specialists to manage complications that adults with congenital heart disease experience with heart failure is pressing. Research in this field is limited by small sample sizes with broad patient heterogeneity. The mainstays of heart failure treatment include goal-directed medical therapies, electrophysiology interventions, mechanical circulatory support, and transplant. Although these therapies have been studied in the adult populations in the more traditional left-sided heart failure, data is limited in the use of these therapies in adults with congenital heart disease. Collaborative guidance is needed to advance the management and care of the fast-growing population of adults with congenital heart disease.
-
7. Evolving Decongestion Strategies in the Management of Acute Heart Failure.
PMID:日期:2025-01-01To provide an overview of the latest evidence-based treatment strategies for acute heart failure (HF), with a significant focus on recent clinical trials and their associated implications within clinical practice. Recent studies have highlighted the effectiveness of urine sodium-guided decongestion, segmental nephron blockade, disease-modifying therapies, and the use of maintenance diuretics. These approaches have demonstrated significant improvements in patient outcomes, including better decongestion, reduced hospital admissions, and improved survival rates. The findings suggest a multifaceted, evidence-based approach is necessary for the effective management of acute HF. Implementing urine sodium-guided decongestion and segmental nephron blockade can enhance diuretic efficiency while disease-modifying therapies improve long-term outcomes. Maintenance diuretics play a crucial role in preventing recurrent hospitalizations.
-
8. Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.
PMID:日期:2025-01-01The goals of this review are to summarize the current literature regarding metabolic abnormalities in heart failure and propose therapies that can induce metabolic reprogramming to benefit the diseased heart. Analysis of cardiac and skeletal muscle metabolism in heart failure has revealed several abnormalities including lower PCr/ATP ratio (indicating diminished myocardial energy reserves), altered substrate utilization, and mitochondrial abnormalities. Several advances in both non-invasive and invasive methods to studying cardiac metabolism have allowed recent key contributions to the field. Promising therapeutic strategies include shifting towards increased utilization of ketones and fatty acids, targeting mitochondrial biogenesis and function, and activation of genes that promote metabolic remodeling. Several current therapies lead to metabolic reprogramming, including both drug and device-based therapies such as cardiac resynchronization therapy (CRT) and left ventricular assist devices (LVADs). Strategies to induce metabolic reprogramming in the diseased heart need further study. Future research should address differences in metabolic abnormalities in HFrEF and HFpEF, methods to study metabolic responses to therapies, and impact of metabolic reprogramming on clinical outcomes in heart failure.
-
9. Emerging Photoacoustic Imaging Techniques for Peripheral Arterial Disease.
9. 用于外周动脉疾病的新兴光声成像技术PMID:日期:2025-01-01Photoacoustic imaging (PAI) has emerged as a promising non-ionizing modality that leverages optical absorption contrast to provide both anatomical and functional insights into vascular health. This review examines recent advances in PAI technologies applied to the diagnosis, assessment, and management of peripheral arterial disease (PAD). The goal is to evaluate how emerging PAI techniques address current diagnostic limitations and to identify opportunities for clinical integration. Recent studies have demonstrated the potential of PAI to capture high-resolution, dynamic images of peripheral vasculature, quantify oxygen saturation and regional blood volume, and assess microvascular health. Technological innovations, including single-shot volumetric imaging, all-optical scanners, and multimodal systems, have expanded PAI's clinical utility. Emerging PAI systems show promise for complementing traditional imaging by providing functional insights into microvascular health. Continued technological development and validation through large-scale studies are essential for establishing PAI's clinical role in PAD diagnosis and management.
-
10. Identifying Responders to Transcatheter Interventions for Secondary Mitral Regurgitation.
PMID:日期:2025-01-01This article offers a comprehensive review of the literature on imaging predictors of response to transcatheter interventions for secondary mitral regurgitation (SMR). Recent advancements in percutaneous valve therapies have broadened treatment options for high-risk patients with SMR. While recent studies have demonstrated significant reduction in all-cause mortality and hospitalizations with transcatheter edge-to-edge repair (TEER), significant controversy remains. This review highlights the central role of multi-modality imaging to guide therapeutic decision making for optimal treatment response and long-term outcomes. Several echocardiographic, computerized tomography (CT) and cardiac magnetic resonance (CMR) imaging parameters are central to identifying optimal conditions for transcatheter therapies. Imaging features have become key predictors of outcomes following transcatheter interventions for secondary mitral regurgitation and provide important risk stratification to guide therapeutic decision making and shared decision making.